red / near-infrared reaches the cell
The science
Light your cells can absorb.
What red and near-infrared light is, where it goes in the body, and what researchers have measured. Explained properly, with every source.
Most pages about red light stop at "it is good for your skin". That tells you nothing. This page starts at the beginning: what light is, why only certain colours get into the body, how far each Lumi wavelength travels, which molecule inside your cells absorbs it, and what researchers have measured in the people they studied. It also tells you where the evidence is thin.
The field has a name, more than 50 years of published research behind it, and a mechanism that can be explained in plain words. 2 9 That is what follows.
This page describes research. It is not a forecast of your result.
The idea
Red light therapy, in one paragraph.
Red light therapy is the use of specific red and near-infrared wavelengths, at modest intensity, to change what cells do. The scientific name is photobiomodulation, or PBM: "photo" for light, "bio" for living tissue, "modulation" for a change in activity. Older papers call it low-level laser (or light) therapy, LLLT. 1 2
The key word is modest. This is not a laser that cuts, a heat lamp that warms, or ultraviolet light that tans. It is light delivered at levels low enough that the effect researchers study is chemical and biological, not thermal. 1 14
The idea in three steps:
cytochrome c oxidase in the mitochondria (and some ion channels in the membrane)
energy production and signalling change, and the cell adjusts what it makes
Every other section on this page unpacks one of those three steps.
Light
Colour is a wavelength. Wavelength decides where light goes.
Light is energy travelling as a wave. The distance from one peak of the wave to the next is its wavelength, measured in nanometres (nm), billionths of a metre. Your eyes read wavelength as colour: violet sits near 400nm, green near 530nm, red runs out to about 700nm. Past that, light carries on but your eyes stop detecting it. That invisible band is near-infrared.
Lumi Core: 630, 660, 810, 830, 850
Lumi Pro adds: 960, 1060
Wavelength does far more than set colour. It decides what happens when light meets the body: how much bounces off the surface, which molecules soak it up, and how far it travels before it is spent.
The three big absorbers in your tissue
| Absorber | Where it is | What it absorbs strongly | Where it absorbs less |
|---|---|---|---|
| Melanin | The pigment in skin | Short visible light (violet, blue) | Less and less through red into near-infrared |
| Haemoglobin | Red blood cells | Blue and green | Much less in deep red and near-infrared |
| Water | Most of soft tissue | Beyond about 900nm, rising steeply | Little in red and the shorter near-infrared |
Between those three there is a gap, roughly 600 to 900nm, where tissue absorbs the least and light travels the furthest. Physicists call it the optical window. It is the reason this whole field works in red and near-infrared, and the reason every Lumi wavelength sits in it or just beyond it. 1 10
Absorption and scattering, the two things that happen to light in skin
Light inside tissue has two fates.
Absorption: a molecule tuned to that wavelength takes in the light's energy. That is the useful event, when the molecule is the right one. When melanin, haemoglobin or water take it instead, that light is no longer available for anything deeper.
Scattering: the light hits cell membranes, collagen fibres and other tiny structures and changes direction, again and again. Scattering does not destroy the light, but it spreads it sideways and sends some back out of the skin. Shorter wavelengths scatter more; longer ones scatter less. 1
Each absorption and each scattering event takes a little light out of the forward beam, so the amount left falls steadily with depth. There is no hard stop. Penetration is a fade, not a wall.
light in
skin surface
some reflects back out
scatter: changes direction
absorbed by melanin / haemoglobin
absorbed by cytochrome c oxidase (the useful event)
less light remains at each depth
Depth
How far the light goes, and what it meets.
Skin is layered, and each layer holds different cells.
a fraction of a millimetre on most of the body. Skin cells (keratinocytes) and pigment cells (melanocytes).
roughly 1 to 4 mm, depending on where on the body. Fibroblasts, the cells that make collagen and elastin. Small blood vessels and the roots of hair follicles.
fat, connective tissue, then muscle, tendon and joint. Muscle is packed with mitochondria.
Red light (630 and 660nm) is absorbed and scattered more, so most of it is spent in the epidermis and dermis: the layer where fibroblasts live. That is why red is the wavelength of skin research.
Near-infrared (810 to 850nm) is absorbed less by melanin, haemoglobin and water, and scatters less, so a larger share passes through the skin and carries on into fat, connective tissue and muscle.
What the measurements show
- A 2017 computer-modelling study of light travelling through a multi-layered model of human skin found that penetration depth increased as wavelength increased, with a deepest calculated value of about 5.4 mm. It also showed that skin tone and the width of the beam change how light is distributed. A 10 mm beam delivered 73 to 88% of the light that an infinitely wide beam delivered at depths of 1 to 3 mm. 10 A panel lighting a large area behaves much more like the wide beam than a narrow spot does.
- A 2015 study measured light passing through eight intact human cadaver heads. A broad 808nm beam travelled through scalp, skull and the brain's protective membranes into brain tissue to a depth of about 40 mm. Inside brain tissue, 808nm was absorbed and scattered less than both 660nm and 940nm. 11
Reading those two numbers properly
They measure different things. The 5.4 mm figure is a modelled depth in skin where most of the light has been used up. The 40 mm figure is how far any measurable light reached. The same cadaver study also reported how quickly the light faded: for that system, the light fell to about a third of its level for roughly every 4.5 mm it travelled. 11 So even the deepest-travelling light does most of its work in the first centimetre or so, and only a small fraction goes further.
The practical point: how much light arrives at any depth depends on how much arrives at the surface. That is why intensity and distance matter, covered under Dose.
Wavelengths
Every Lumi wavelength, explained.
The molecule at the centre of this field, cytochrome c oxidase, does not respond to all red and near-infrared light equally. In a 2005 analysis, researchers fitted seven action spectra (graphs of how strongly cells respond at each wavelength) from human cells lit with 580 to 860nm light and found four active bands: a red band peaking between about 613 and 624nm, a far-red band between about 668 and 684nm, and two near-infrared bands at about 751 to 772nm and 813 to 846nm. 6 Lumi Core's five wavelengths sit on or beside those bands. Pro adds two longer wavelengths that reach cells by different routes.
| nm | 600 | 650 | 700 | 750 | 800 | 850 |
|---|---|---|---|---|---|---|
| bands | 613-624 | 668-684 | 751-772 | 813-846 | ||
| Lumi | 630 | 660 | 810 | 830, 850 | ||
Tap a wavelength to open it.
- How far it travels
- The shortest-travelling light on a Lumi panel. Most of its energy is spent in the epidermis and the upper dermis, the outer few millimetres of skin. 10
- What it reaches
- Skin cells at the surface and fibroblasts in the dermis.
- What absorbs it
- Cytochrome c oxidase, close to its red absorption band, which peaks between about 613 and 624nm. 6 Melanin and haemoglobin compete for it on the way, which is one reason it does not travel far.
- What happens
- Absorption by cytochrome c oxidase is linked to faster electron transport and more ATP, followed by a brief signalling burst that changes gene activity in the cell (see The cell). 2 3 In the dermis, the cells doing that work are fibroblasts. 633nm, a close neighbour, was one of the settings in a 2007 trial that found more collagen and elastic fibres in skin samples. 17
- How far it travels
- A little further than 630nm, still largely spent within the skin. In a 2015 measurement inside human brain tissue, 660nm was absorbed and scattered more than 808nm, which is why it is a skin wavelength rather than a deep one. 11
- What it reaches
- The full depth of the dermis, including the area around hair follicles and the small blood vessels of the skin.
- What absorbs it
- Cytochrome c oxidase, just below its far-red band of about 668 to 684nm. 6
- How far it travels
- Well past the skin. 808nm, effectively the same wavelength, reached about 40 mm through the scalp and skull in human cadaver measurements, and was absorbed and scattered less than 660 or 940nm. 11
- What it reaches
- Through the dermis into fat, connective tissue and muscle.
- What absorbs it
- Cytochrome c oxidase, just below its main near-infrared band of about 813 to 846nm. 6 A 2017 study in human stem cells concluded that 810nm acts largely through cytochrome c oxidase in the mitochondria. 12
- What happens
- In that study, 810nm raised cell growth with a classic biphasic pattern, peaking at 3 J/cm² and doing less above it. 12 It is the reference wavelength for the mitochondrial pathway described under The cell.
- How far it travels
- Like 810nm, through the skin into the tissue beneath. Little is lost to pigment or blood on the way.
- What it reaches
- The deep dermis, connective tissue and muscle.
- What absorbs it
- Cytochrome c oxidase, inside its main near-infrared band. 6
- How far it travels
- Past the skin into fat, connective tissue and muscle. Melanin absorbs less of it than red, so skin tone has less effect on how much gets through. 10
- What it reaches
- Muscle and other mitochondria-rich tissue.
- What absorbs it
- Cytochrome c oxidase, at the upper edge of its main near-infrared band. 6
- How far it travels
- Less far than 810 to 850nm. It sits on a water absorption band near 970nm, so water in tissue takes up more of it. Inside brain tissue, 940nm, a near neighbour, was absorbed and scattered more than 808nm. 11 It is a different tool, not a deeper version of 850nm.
- What it reaches
- Mainly the skin and the tissue just beneath.
- What absorbs it
- Water in and around cells. A 2017 study in human stem cells found that 980nm, a near neighbour, worked through temperature-gated calcium channels in the cell membrane (TRPV1 and TRPC), not through mitochondria. The researchers' explanation is that water absorbs the light and creates tiny local temperature gradients that open those channels. 12
- What happens
- In that study, 980nm raised calcium inside the cell, and its best dose was 10 to 100 times lower than the best dose for 810nm. 12 This is the second pathway described under The cell. Research in people is still early.
- How far it travels
- Past the 970nm water band, water absorbs less again, and scattering keeps falling as wavelength rises, so this light reaches tissue beyond the skin. A 2017 study delivered 1064nm light through the forehead and measured changes in the brain tissue beneath. 13
- What it reaches
- Deeper tissue beyond the skin.
- What absorbs it
- Cytochrome c oxidase is still a target at this wavelength. In that study of 11 healthy adults, 1064nm light on the forehead raised the level of oxidised cytochrome c oxidase in the brain tissue beneath, compared with placebo. The authors described it as the first demonstration of this effect in the human brain. 13
- What happens
- The same study measured rises in oxygenated and total haemoglobin during and after the light, and found that the change in cytochrome c oxidase tracked the change in blood oxygen supply. 13 Early, carefully measured, and not yet settled.
| Wavelength | Colour | Travels | Main layer reached | Main absorber in the cell | Main pathway |
|---|---|---|---|---|---|
| 630nm | Red | Shortest | Epidermis, upper dermis | Cytochrome c oxidase (red band) | Mitochondrial |
| 660nm | Red | Short | Dermis | Cytochrome c oxidase (far-red band) | Mitochondrial |
| 810nm | Near-infrared | Furthest | Fat, connective tissue, muscle | Cytochrome c oxidase (near-infrared band) | Mitochondrial |
| 830nm | Near-infrared | Furthest | Deep dermis, connective tissue, muscle | Cytochrome c oxidase (near-infrared band) | Mitochondrial |
| 850nm | Near-infrared | Furthest | Fat, connective tissue, muscle | Cytochrome c oxidase (near-infrared band) | Mitochondrial |
| 960nm (Pro) | Near-infrared | Shorter than 810 to 850 | Skin and just beneath | Water | Heat-gated ion channels |
| 1060nm (Pro) | Near-infrared | Beyond the skin | Deeper tissue | Cytochrome c oxidase | Mitochondrial, early research |
"Travels" compares the wavelengths with each other. Exact depths depend on skin tone, body site and how much light arrives at the surface. 10
The cell
What happens in the first seconds.
This is the part most brands skip. It is also the part that explains everything else: why wavelength matters, why dose matters, and why more is not always better.
red / near-infrared light
- 1 absorbed by cytochrome c oxidase in the mitochondria
- 2 nitric oxide is knocked off the enzyme
- 3 electron transport speeds up, more ATP (cell energy)
- 4 a brief burst of reactive oxygen species (a signal, not damage)
- 5 also: light- and heat-gated ion channels let calcium in
- 6 messengers (ROS, cyclic AMP, nitric oxide, calcium) switch on transcription factors
- 7 genes change: proteins for repair, movement, growth, antioxidant defence and lower inflammatory signalling
The power station
Almost every cell in the body contains mitochondria, small structures that use oxygen and nutrients to make adenosine triphosphate, or ATP. ATP is the energy currency cells spend on everything: building proteins, repairing damage, dividing, contracting and signalling.
The light-sensitive enzyme
ATP is made at the end of a chain of proteins in the mitochondria called the electron transport chain. One of the last links is cytochrome c oxidase (complex IV of the chain). It contains copper and haem centres, and those centres absorb red and near-infrared light. Its absorption bands line up with the wavelengths that produce effects in the lab, which is why researchers describe it as the primary photoacceptor in this field. 2 5 6
Releasing the brake
Nitric oxide, a small signalling molecule, can bind to cytochrome c oxidase and get in the way of oxygen, slowing the whole chain. The leading hypothesis is that red and near-infrared photons knock that nitric oxide off the enzyme. Electron transport speeds up, the electrical charge across the mitochondrial membrane rises, and ATP production increases. 2 4
A brief signal
When mitochondria speed up, they release a short burst of reactive oxygen species, or ROS. In large amounts, ROS damage cells. In small, brief pulses, they are messengers. Reviews of the field list a rise in ATP, a brief burst of ROS, an increase in nitric oxide and a change in calcium levels as the secondary effects of light absorption. 3
The same signal behaves differently depending on the state of the cell. In normal cells, light produces a small rise in ROS and can switch on NF-κB, a master switch for genes involved in cell survival. In cells already under oxidative stress, light has been reported to lower ROS and lift the cell's own antioxidant defences. In activated inflammatory cells, inflammatory markers fell. 3 4 Researchers describe this as one signal with apparently opposite effects, depending on the state of the cell.
The second pathway
Mitochondria are not the only target. Light-sensitive and heat-gated ion channels in the cell membrane can open when light is absorbed, letting calcium into the cell. Reviews suggest some of these channels may respond through light-absorbing proteins called opsins. 2 3 This route appears to dominate at longer wavelengths near 980nm, where water is the absorber. 12
From signal to genes
After the first absorption step, the message is passed along by ROS, cyclic AMP, nitric oxide and calcium. Transcription factors switch on, and the cell changes which genes it reads. The genes involved relate to protein synthesis, cell migration and multiplication, anti-inflammatory signalling, proteins that resist cell death, and antioxidant enzymes. Stem cells and progenitor cells appear especially responsive. 2
The sequence in one line: light is absorbed, the brake comes off, energy rises, a brief signal fires, and the cell changes what it makes next.
Cell to tissue
What that looks like in skin, blood and muscle.
Fibroblasts and collagen
Fibroblasts are the cells in the dermis that spin collagen and elastin, the proteins that give skin its firmness and spring. They sit in the zone where red light is absorbed. Reviews of light in skin describe a chain in skin cells: absorption by mitochondrial chromophores, then electron transport, ATP, nitric oxide release, blood flow, ROS and a range of signalling pathways, with stem cells involved in repair also activated. 15 16
What researchers saw under the microscope: in a 2007 randomised, sham-controlled trial, skin samples taken after a course of 633nm, 830nm or combined LED light showed a marked increase in collagen and elastic fibres, and electron microscopy showed highly activated fibroblasts surrounded by abundant fibres. 17 In a 2014 controlled trial of 136 volunteers, collagen density measured by ultrasound improved in the light groups compared with controls. 19
Blood flow and oxygen
Nitric oxide is also the body's own signal for widening blood vessels, so its release is one proposed link between light and local blood flow. 2 15 In a 2017 human study of 1064nm light on the forehead, oxygenated and total haemoglobin rose in the tissue beneath during and after the light, compared with placebo. 13 More oxygen arriving is what busier mitochondria need.
Inflammatory signalling
Reviews describe an overall reduction in inflammation as one of the most reproducible effects of photobiomodulation, and single out joints and traumatic injuries as areas where it matters. Reported changes include lower inflammatory markers in activated immune cells and lower markers of the pro-inflammatory M1 type of macrophage, the immune cells that clear damage. 3 In the 2007 skin trial, levels of the inflammatory messenger IL-6 fell in skin samples after the LED course. 17
Muscle
Muscle is packed with mitochondria, which makes it one of the most light-responsive tissues studied. A 2016 review of 46 studies with 1,045 participants, from untrained volunteers to elite athletes, reported that light could increase muscle mass gained after training and decrease inflammation and oxidative stress in muscle biopsies. 34 A 2018 review notes that light can act as a preconditioning step and can interact with exercise in muscle. 4
Together
Why a panel runs more than one wavelength.
A single wavelength only covers the depth it reaches and the pathway it drives. Combining them is a coverage decision, and there are three reasons for it.
- Depth. Red is spent in the skin, where fibroblasts make collagen. Near-infrared carries past it into muscle and connective tissue. Running both means the same session reaches the surface and the tissue beneath it. 10 11
- More than one absorption band. Cytochrome c oxidase has four active bands between 600 and 860nm, and their exact peaks vary from one measurement to the next. 6 Five wavelengths spread across 630 to 850nm put light on or beside each band rather than betting on one.
- More than one pathway. 810nm acts mainly through mitochondria; 980nm acts mainly through heat-gated ion channels. 12 Pro's 960 and 1060nm add longer wavelengths that reach cells by a different route and to a different depth.
| 630 | 660 | 810 | 830 | 850 | 960 | 1060 | |
|---|---|---|---|---|---|---|---|
| epidermis | ### | ### | ... | ... | ... | ## | .. |
| dermis | ## | ### | ## | ## | ## | # | ## |
| beneath skin | . | . | ### | ### | ### | . | ## |
| pathway | mitochondria | ion channels | mitochondria (early research) | ||||
### most light. ## some. # little. . trace
What the trials combined: many of the studies on this page used more than one wavelength. The 2007 skin trial tested 633nm alone, 830nm alone and both together, and all three groups showed changes compared with baseline. 17 A 2005 facial study combined 633 and 830nm, a 2009 leg ulcer trial combined 660 and 890nm, and a 2015 volleyball trial combined 630 and 850nm. 18 25 35
The honest note: combining wavelengths is a logic of coverage, not proof that more wavelengths add up to more effect. A 2014 trial of 136 people found that a broad 570 to 850nm spectrum showed no advantage over red alone for the skin measures it tracked. 19 That is why Lumi does not sell a longer wavelength list for its own sake.
How Lumi runs them:
| Range | Wavelengths | How they run |
|---|---|---|
| Core: Mini, Half Body, Full Body, Ultra | 630, 660, 810, 830, 850nm | All five together, on a simple timer |
| Pro: Pro Mini, Pro Half, Pro Full | 630, 660, 810, 830, 850, 960, 1060nm | Touchscreen. Set each of the seven, including pulse and time, and save up to three modes |
Dose
Dose is intensity multiplied by time.
Two devices with the same wavelengths can deliver very different sessions, because what reaches the cells depends on dose. Wattage tells you how much electricity a device draws from the wall. It does not tell you how much light lands on the skin. Three numbers do.
The intensity of light arriving at a surface, in milliwatts per square centimetre. Think of it as brightness at the skin. It falls as you move away from the light source.
How long that patch of skin is in the light.
Irradiance multiplied by time gives the energy delivered to each square centimetre, in joules per square centimetre. When researchers talk about dose, this is usually what they mean.
Dose (J/cm²) = irradiance (mW/cm²) × time (seconds) ÷ 1,000
Worked example (illustration only, not a Lumi figure): A light source measured at 50 mW/cm² at the skin, for 10 minutes (600 seconds): 50 × 600 ÷ 1,000 = 30 J/cm². Halve the irradiance and the same 10 minutes delivers 15 J/cm². Double the time and the dose doubles.
| Illustration at 50 mW/cm² | 5 minutes | 10 minutes | 20 minutes |
|---|---|---|---|
| Dose at the skin | 15 J/cm² | 30 J/cm² | 60 J/cm² |
That is light at the skin surface, not light inside the body. Because light fades with depth, the dose at a fibroblast or a muscle cell is a fraction of the surface figure. 10 11
The biphasic dose response
This is the most important idea in the field, and the one hype ignores. Researchers have repeatedly observed that low levels of light stimulate and support tissue better than high levels: too little does little, a moderate dose works best, and a much larger dose can inhibit the very response being studied. It is called the biphasic dose response, often drawn as the Arndt-Schulz curve. 1 7 8
A real example from a cell study: 810nm light peaked at 3 J/cm² for stimulating stem cell growth, and 980nm peaked at a dose 10 to 100 times lower. 12 A real example from people: in the 2015 volleyball trial, a middle dose of 210 J per muscle group was followed by a 10% rise in a muscle damage marker after matches, against a 53% rise with no light. The lowest dose (105 J) was followed by a 59% rise, and the highest (315 J) by 31%. 35 The middle dose did best.
A 2018 review that plotted the parameters of a large body of studies found that tissues packed with mitochondria (muscle, brain, heart, nerve) tended to respond to lower doses than tissues with fewer (skin, tendon, cartilage), and that failed studies in mitochondria-rich tissue were more often overdosed than underdosed. The same review notes there is still no agreed protocol: some groups recommend about 4 to 10 J/cm² at the target tissue, others as much as 50 J/cm² at the surface. 9
The practical lesson: a longer or closer session is not automatically a better one.
What doses did the trials use?
Surface doses across the trials on this page vary widely. A 2014 skin trial normalised its red light to about 9 J/cm² per session. 19 A 2005 facial study used 126 J/cm² at 633nm and 66 J/cm² at 830nm. 18 A 2006 acne study used 96 J/cm² of red per session. 21 Two hair trials delivered about 67 J/cm² per 25-minute session. 26 27 A 2009 leg ulcer trial used 3 J/cm². 25 There is no single right number, which is exactly what the 2018 review found. 9
Why distance and time are your two dials
Light spreads out as it leaves a device, so the further away the skin is, the less light lands on each square centimetre. For a single point of light, intensity falls with the square of distance: twice as far, a quarter of the intensity. A panel is a large grid of LEDs, so close up it falls more gently, and further away it falls faster. Either way, a few centimetres change the number a lot.
That gives two dials. Distance sets irradiance. Time sets how long that irradiance is delivered. Keeping both the same from session to session keeps the dose the same. Moving closer concentrates light on a smaller area and adds warmth; stepping back covers more of the body, more evenly.
How to read anyone's irradiance claims
An irradiance number means nothing without the distance it was measured at, and the instrument it was measured with. A reading taken a few centimetres from the LEDs will always beat one taken where you actually sit, and meters built for sunlight are not designed for the narrow wavelength bands of LEDs. That is why this page explains how dose works rather than turning any manufacturer figure, ours included, into a dose chart.
The research
What researchers have studied.
Below is what researchers measured when they put people under red and near-infrared light, topic by topic, with how the light is thought to act in that tissue. Each line describes what happened to the participants in that study. Devices, wavelengths and doses differ from study to study and from Lumi panels, many studies used lasers rather than LEDs, and individual results vary. Read The limits next; it matters.
Skin and collagen
How the light is thought to act: red at 630 to 660nm is absorbed in the dermis, where fibroblasts make collagen and elastin; near-infrared reaches the deeper dermis. 15 16
- A 2007 randomised, double-blind, sham-controlled split-face trial of 76 people with facial wrinkles used 830nm, 633nm, both, or a sham light, twice a week for four weeks. Objective measurements showed wrinkle reductions of up to 36% and gains in skin elasticity of up to 19% compared with baseline in the three active groups. Skin samples showed a marked increase in collagen and elastic fibres and highly activated fibroblasts. No adverse effects were reported. 17
- A 2005 study gave 31 people nine sessions of combined 633nm and 830nm LED light. By week 12, 52% showed a 25 to 50% improvement in photoageing scores, and 81% reported a significant improvement in wrinkles around the eyes. 18
- A 2014 randomised, controlled trial of 136 volunteers used large-area light sources (red at 611 to 650nm, or a broad 570 to 850nm spectrum) twice a week for 30 sessions. Participants in the light groups showed significantly improved skin complexion, skin feel, skin roughness and ultrasound-measured collagen density, and blinded assessment of photographs confirmed improvement compared with controls. The broad spectrum showed no advantage over red alone. 19
Acne
How the light is thought to act: blue light acts on the bacteria involved in acne. Red reaches deeper into the skin and is thought to act mainly on inflammation, which is why trials usually pair them. 20 Lumi panels do not include blue, so the red half of this research is the relevant part.
- A 2000 trial randomised 107 people with mild to moderate acne to blue light, mixed blue and red (415 and 660nm), white light, or benzoyl peroxide cream. After 12 weeks of daily 15-minute sessions, the blue and red group showed a mean 76% improvement in inflammatory lesions, significantly better than white light at every assessment and better than benzoyl peroxide at weeks 8 and 12. The authors credited a combination of antibacterial and anti-inflammatory action. 20
- A 2006 study of 24 people with mild to severe acne alternated 415nm blue and 633nm red LED sessions twice a week for four weeks, alongside mild microdermabrasion. Mean lesion counts fell by 46% at the 4-week follow-up and 81% at the 12-week follow-up. There was no control group. 21
- A 2007 study of 24 people with skin type IV and mild to moderately severe acne alternated 415nm blue and 633nm red, twice weekly for four weeks. Inflammatory lesions improved by a mean of 77.9%, and 14 participants spontaneously reported brighter skin tone and better texture. 22
Psoriasis
How the light is thought to act: psoriasis is driven by inflammation in the skin, and lower inflammatory signalling is one of the most consistent effects of red and near-infrared light in the lab. 3
- A 2010 preliminary study of nine people with chronic psoriasis, most of whom had not responded to conventional care, used 830nm and 633nm LED arrays in two 20-minute sessions, 48 hours apart, over four or five weeks. Clearance at follow-up ranged from 60 to 100%. There was no control group, and the author called for a proper controlled trial. 23
- A 2012 double-blind, randomised study of 20 people with psoriasis lit one plaque with high-dose blue light and another with high-dose red, three times a week for four weeks. Both improved in scaling and thickness. Redness kept improving under blue throughout, while under red it stopped improving after six sessions. 24
Wound repair
How the light is thought to act: repair needs energy, new cells and new collagen, all downstream of the mitochondrial and signalling pathways described above. 2 15
- A 2009 double-blind, randomised, placebo-controlled trial studied 23 chronic diabetic leg ulcers that had not responded to other care, using combined 660 and 890nm LED light at 3 J/cm² twice a week alongside standard dressings. By day 90, 58.3% of the ulcers in the light group had closed fully and 75% had reached 90 to 100% closure. Only one ulcer in the placebo group closed fully. 25
Hair
How the light is thought to act: hair follicles are highly active, energy-hungry structures, and red light is absorbed at the depth where they sit. 15
- A 2013 double-blind, randomised trial gave 44 men with pattern hair loss a helmet of 655nm lasers and LEDs, used at home every other day for 16 weeks (60 sessions of 25 minutes). The active group showed a 39% increase in hair counts compared with placebo. 26
- A 2014 trial of the same kind of device in 47 women with pattern hair loss found a 37% increase in hair growth in the active group compared with placebo. No adverse events were reported in either trial. 27
- A 2014 set of multicentre, sham-controlled trials randomised 269 men and women to a 655nm laser comb or a sham, three times a week for 26 weeks. Terminal hair density rose by 18.4 to 25.7 hairs per square centimetre in the active groups, against 1.6 to 9.4 in the sham groups. 28
- A 2009 multicentre trial of 110 men who completed the study also found a significantly greater increase in hair density with a 655nm laser comb than with a sham. 29
Joints
How the light is thought to act: near-infrared at 785 to 860nm passes through skin towards the joint and the tissue around it, where lower inflammation is the leading explanation. Reviews single out joint disorders as an area where this matters. 3
- A 2019 meta-analysis pooled 22 randomised, placebo-controlled trials with 1,063 people with knee osteoarthritis. Pain fell significantly more with light than with placebo at the end of the course and at follow-ups one to 12 weeks later, and disability scores also fell. The authors reported the effect at 4 to 8 J per point with 785 to 860nm. No adverse events were reported. 30
- A 2005 Cochrane review of five placebo-controlled trials with 222 people with rheumatoid arthritis found lower pain, about 27.5 minutes less morning stiffness and better hand flexibility with light than with placebo. 31
- A 2009 meta-analysis in The Lancet, led by a Sydney researcher, pooled 16 randomised trials with 820 people with neck pain. In trials reporting pain scores, pain intensity fell by about 20 mm on a 100 mm scale, and in chronic neck pain the difference persisted up to 22 weeks after the sessions ended. 32
Most of this joint research used lasers applied to specific points, not panels. The limits section explains why that matters.
Muscle performance and recovery
How the light is thought to act: muscle is dense with mitochondria, and near-infrared at 810 to 850nm reaches it through the skin. The leading explanations are more energy available during effort and less oxidative stress and inflammation after it. 4 34
- A 2015 meta-analysis of 13 good-quality randomised trials found that light applied before exercise increased the number of repetitions by about 5.5 and time to exhaustion by about 4 seconds compared with placebo. The most consistent results came from red or near-infrared light applied before exercise. 33
- A 2016 review of 46 studies with 1,045 participants covered fatigue, repetitions, torque, muscle growth, creatine kinase (a blood marker of muscle damage) and delayed-onset muscle soreness. The reviewers reported that light could increase muscle mass gained after training and decrease inflammation and oxidative stress in muscle biopsies. Studies used lasers, LED clusters and flexible LED arrays. 34
- A 2015 double-blind trial on a professional men's volleyball team (12 athletes) applied an array of 850nm and 630nm LEDs to the thighs and calves before four national championship matches. With no light, creatine kinase rose 53% after a match. At the 210 J dose, it rose 10%. The lowest dose did not prevent the rise. 35
Sleep
How the light is thought to act: one study measured melatonin, the hormone that signals night to the body, before and after a course of evening red light. 36
- A 2012 study of 20 elite female basketball players gave half of them 30 minutes of whole-body red light every night for 14 days. The light group showed better sleep quality scores, higher blood melatonin and better 12-minute run performance than the group without light, and changes in sleep quality tracked changes in melatonin. 36 It was a small study without a sham light, so it is an interesting signal rather than a conclusion.
Fibromyalgia
How the light is thought to act: fibromyalgia involves widespread pain and tenderness, and the anti-inflammatory effects described above are the leading explanation for what researchers measured. 3
- A 2002 single-blind, placebo-controlled trial of 40 women with fibromyalgia gave low-power laser or placebo laser daily for two weeks, weekends excepted. Afterwards, the laser group scored significantly better than placebo on pain, muscle spasm, morning stiffness and tender point count. 37
- A 2019 meta-analysis of nine randomised trials with 325 people found greater improvements in fibromyalgia impact scores, pain, tender points, fatigue, stiffness, depression and anxiety with laser than with placebo. It also found laser added nothing extra on top of a standard exercise programme, and the reviewers rated study quality low to moderate. 38
Brain energy metabolism (emerging)
- A 2017 study of 11 healthy adults found that 1064nm laser light on the forehead increased oxidised cytochrome c oxidase and oxygenated haemoglobin in the brain tissue beneath, compared with placebo. The authors called it the first demonstration of this effect in the human brain. 13 Early science, worth watching.
Where the field is formally recognised
In 2019, the Multinational Association of Supportive Care in Cancer and the International Society of Oral Oncology (MASCC/ISOO) published clinical practice guidelines recommending specific photobiomodulation protocols for oral mucositis, a painful inflammation of the mouth caused by some cancer therapies, in defined patient groups. 39 It is a clinical, professionally delivered use with precise protocols, and it is not what a home panel is for. It is included because it shows how seriously this science is taken when the protocol is right.
The limits
What the research does not tell you.
Authority means being clear about the gaps as well as the findings.
- Many trials are small. Several of the skin, acne and psoriasis studies above enrolled between 9 and 76 people. Meta-analyses pool more, but they can only be as good as the trials inside them, and some reviewers rate those trials low to moderate in quality. 38
- Much of it used lasers, not LED panels. Much of the foundational and joint research used lasers applied to specific points. Laser and LED light differ, and reviewers caution against assuming results transfer automatically. 14
- Parameters vary enormously. Wavelength, intensity, dose, timing and frequency differ from study to study, and the field has no agreed protocol. That complexity is one reason the literature contains negative studies as well as positive ones. 7 9
- Some trials were not blinded or had no sham or control group. Those are flagged above.
- Some areas are early. Sleep research and brain research in people are thin or preliminary.
- Laboratory cell studies explain mechanism. They do not show what happens in a whole person.
- A study result describes the people in that study. It is not a forecast of yours.
What is solid: the physics of the optical window, the identification of cytochrome c oxidase as a key photoacceptor, the biphasic dose response, and a body of randomised, placebo-controlled trials across skin, hair, joints and muscle that is larger than most people realise. 1 2 7 30 34
Lumi products are not therapeutic goods and are not intended to diagnose, treat, cure or prevent any disease or medical condition. Information here is general and is not medical advice. If you're pregnant, have a medical condition, or take medication that makes you sensitive to light, check with your doctor before use.
A session
A session, built on the science.
Everything above comes down to a few habits.
- Bare skin. Clothing blocks most red and near-infrared light, so uncover the area you want in the light.
- Pick a distance, then keep it. Most panel sessions are 15 to 30 cm away. Closer concentrates the light; further covers more of the body. Keeping it the same each time keeps the dose the same.
- About ten minutes. Most panel sessions are about ten minutes. Longer is not better by default. Remember the curve.
- Consistency over intensity. The trials on this page ran sessions from twice a week to daily, for weeks or months.
- Protect your eyes. Eyes closed, or the glasses on, whenever the light is at face height. Near-infrared is invisible, so your eyes do not squint against it.
- Follow the guide in the box.
Pro owners: start with a preset, then use the touchscreen to shift the balance between red and near-infrared, or turn 960 and 1060nm up and down. Change one setting at a time and keep it for a few weeks before changing another.
Questions
Questions people actually ask.
Shop
Now choose your coverage.
Mini, Half Body, Full Body or Ultra for the area you want to cover. Pro if you'd like to set every wavelength yourself. Glow Mask or Halo for a hands-free face ritual.
Shop all productsReferences
References.
Every study cited on this page, with a link to its PubMed record and, where available, the free full text. Checked 7 October 2026.
Mechanism, physics and dose
- Chung H, Dai T, Sharma SK, Huang YY, Carroll JD, Hamblin MR. The nuts and bolts of low-level laser (light) therapy. Ann Biomed Eng. 2012;40(2):516-33. PubMed Full text
- de Freitas LF, Hamblin MR. Proposed mechanisms of photobiomodulation or low-level light therapy. IEEE J Sel Top Quantum Electron. 2016;22(3):7000417. PubMed Full text
- Hamblin MR. Mechanisms and applications of the anti-inflammatory effects of photobiomodulation. AIMS Biophys. 2017;4(3):337-361. PubMed Full text
- Hamblin MR. Mechanisms and mitochondrial redox signaling in photobiomodulation. Photochem Photobiol. 2018;94(2):199-212. PubMed Full text
- Karu TI. Multiple roles of cytochrome c oxidase in mammalian cells under action of red and IR-A radiation. IUBMB Life. 2010;62(8):607-10. PubMed
- Karu TI, Kolyakov SF. Exact action spectra for cellular responses relevant to phototherapy. Photomed Laser Surg. 2005;23(4):355-61. PubMed
- Huang YY, Chen AC, Carroll JD, Hamblin MR. Biphasic dose response in low level light therapy. Dose Response. 2009;7(4):358-83. PubMed Full text
- Huang YY, Sharma SK, Carroll J, Hamblin MR. Biphasic dose response in low level light therapy: an update. Dose Response. 2011;9:602-18. PubMed Full text
- Zein R, Selting W, Hamblin MR. Review of light parameters and photobiomodulation efficacy: dive into complexity. J Biomed Opt. 2018;23(12):1-17. PubMed Full text
- Ash C, Dubec M, Donne K, Bashford T. Effect of wavelength and beam width on penetration in light-tissue interaction using computational methods. Lasers Med Sci. 2017;32(8):1909-1918. PubMed Full text
- Tedford CE, DeLapp S, Jacques S, Anders J. Quantitative analysis of transcranial and intraparenchymal light penetration in human cadaver brain tissue. Lasers Surg Med. 2015;47(4):312-22. PubMed
- Wang Y, Huang YY, Wang Y, Lyu P, Hamblin MR. Photobiomodulation of human adipose-derived stem cells using 810nm and 980nm lasers operates via different mechanisms of action. Biochim Biophys Acta Gen Subj. 2017;1861(2):441-449. PubMed Full text
- Wang X, Tian F, Reddy DD, et al. Up-regulation of cerebral cytochrome-c-oxidase and hemodynamics by transcranial infrared laser stimulation: a broadband near-infrared spectroscopy study. J Cereb Blood Flow Metab. 2017;37(12):3789-3802. PubMed Full text
- Glass GE. Photobiomodulation: a review of the molecular evidence for low level light therapy. J Plast Reconstr Aesthet Surg. 2021;74(5):1050-1060. PubMed
Skin
- Avci P, Gupta A, Sadasivam M, et al. Low-level laser (light) therapy (LLLT) in skin: stimulating, healing, restoring. Semin Cutan Med Surg. 2013;32(1):41-52. PubMed Full text
- Barolet D. Light-emitting diodes (LEDs) in dermatology. Semin Cutan Med Surg. 2008;27(4):227-38. PubMed
- Lee SY, Park KH, Choi JW, et al. A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation: clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings. J Photochem Photobiol B. 2007;88(1):51-67. PubMed
- Russell BA, Kellett N, Reilly LR. A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation. J Cosmet Laser Ther. 2005;7(3-4):196-200. PubMed
- Wunsch A, Matuschka K. A controlled trial to determine the efficacy of red and near-infrared light treatment in patient satisfaction, reduction of fine lines, wrinkles, skin roughness, and intradermal collagen density increase. Photomed Laser Surg. 2014;32(2):93-100. PubMed Full text
Acne and psoriasis
- Papageorgiou P, Katsambas A, Chu A. Phototherapy with blue (415 nm) and red (660 nm) light in the treatment of acne vulgaris. Br J Dermatol. 2000;142(5):973-8. PubMed
- Goldberg DJ, Russell BA. Combination blue (415 nm) and red (633 nm) LED phototherapy in the treatment of mild to severe acne vulgaris. J Cosmet Laser Ther. 2006;8(2):71-5. PubMed
- Lee SY, You CE, Park MY. Blue and red light combination LED phototherapy for acne vulgaris in patients with skin phototype IV. Lasers Surg Med. 2007;39(2):180-8. PubMed
- Ablon G. Combination 830-nm and 633-nm light-emitting diode phototherapy shows promise in the treatment of recalcitrant psoriasis: preliminary findings. Photomed Laser Surg. 2010;28(1):141-6. PubMed
- Kleinpenning MM, Otero ME, van Erp PE, Gerritsen MJ, van de Kerkhof PC. Efficacy of blue light vs. red light in the treatment of psoriasis: a double-blind, randomized comparative study. J Eur Acad Dermatol Venereol. 2012;26(2):219-25. PubMed
Wound repair
- Minatel DG, Frade MA, França SC, Enwemeka CS. Phototherapy promotes healing of chronic diabetic leg ulcers that failed to respond to other therapies. Lasers Surg Med. 2009;41(6):433-41. PubMed
Hair
- Lanzafame RJ, Blanche RR, Bodian AB, et al. The growth of human scalp hair mediated by visible red light laser and LED sources in males. Lasers Surg Med. 2013;45(8):487-95. PubMed
- Lanzafame RJ, Blanche RR, Chiacchierini RP, Kazmirek ER, Sklar JA. The growth of human scalp hair in females using visible red light laser and LED sources. Lasers Surg Med. 2014;46(8):601-7. PubMed Full text
- Jimenez JJ, Wikramanayake TC, Bergfeld W, et al. Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol. 2014;15(2):115-27. PubMed Full text
- Leavitt M, Charles G, Heyman E, Michaels D. HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: a randomized, double-blind, sham device-controlled, multicentre trial. Clin Drug Investig. 2009;29(5):283-92. PubMed
Joints and pain
- Stausholm MB, Naterstad IF, Joensen J, et al. Efficacy of low-level laser therapy on pain and disability in knee osteoarthritis: systematic review and meta-analysis of randomised placebo-controlled trials. BMJ Open. 2019;9(10):e031142. PubMed Full text
- Brosseau L, Robinson V, Wells G, et al. Low level laser therapy (Classes I, II and III) for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2005;(4):CD002049. PubMed Full text
- Chow RT, Johnson MI, Lopes-Martins RA, Bjordal JM. Efficacy of low-level laser therapy in the management of neck pain: a systematic review and meta-analysis of randomised placebo or active-treatment controlled trials. Lancet. 2009;374(9705):1897-908. PubMed
Muscle, sleep and fibromyalgia
- Leal-Junior EC, Vanin AA, Miranda EF, et al. Effect of phototherapy (low-level laser therapy and light-emitting diode therapy) on exercise performance and markers of exercise recovery: a systematic review with meta-analysis. Lasers Med Sci. 2015;30(2):925-39. PubMed
- Ferraresi C, Huang YY, Hamblin MR. Photobiomodulation in human muscle tissue: an advantage in sports performance? J Biophotonics. 2016;9:1273-1299. PubMed Full text
- Ferraresi C, Dos Santos RV, Marques G, et al. Light-emitting diode therapy (LEDT) before matches prevents increase in creatine kinase with a light dose response in volleyball players. Lasers Med Sci. 2015;30(4):1281-7. PubMed
- Zhao J, Tian Y, Nie J, Xu J, Liu D. Red light and the sleep quality and endurance performance of Chinese female basketball players. J Athl Train. 2012;47(6):673-8. PubMed Full text
- Gür A, Karakoç M, Nas K, et al. Efficacy of low power laser therapy in fibromyalgia: a single-blind, placebo-controlled trial. Lasers Med Sci. 2002;17(1):57-61. PubMed
- Yeh SW, Hong CH, Shih MC, Tam KW, Huang YH, Kuan YC. Low-level laser therapy for fibromyalgia: a systematic review and meta-analysis. Pain Physician. 2019;22(3):241-254. PubMed
Clinical guidelines
- Zadik Y, Arany PR, Fregnani ER, et al. Systematic review of photobiomodulation for the management of oral mucositis in cancer patients and clinical practice guidelines. Support Care Cancer. 2019;27(10):3969-3983. PubMed